Los Angeles, CA (PRWEB) September 29, 2012
The annual Prostate Cancer Conference was held the weekend of September 7-9 in the Marriott LAX Hotel, and attracted more than 800 attendees from approximately 35 states and seven countries.
The conference, which is organized every year by the Prostate Cancer Research Institute, is the largest conference catered specifically towards patients of the disease.
The event offers a rare opportunity for men and their loved ones to attend lectures and in-depth seminars by some of the world’s leading faculty in the various disciplines of prostate cancer research and education, including radiation, surgery, sexual side effects, hormone therapy, immunotherapy, chemotherapy,and many more. In addition, support groups are offered throughout the weekend, allowing both men and women to share their experiences in an intimate, supportive setting.
In addition to learning from experts in the field about the latest advances in prostate cancer treatment, attendees at the conference also had the chance to attend the Saturday Night Gala Dinner, where the Harry Pinchot and Catalyst awards were presented. The Pinchot award is named in honor of the late “Helpline Harry” Pinchot, and recognizes men and women who spend their time advocating and educating men about prostate cancer. This year’s winners were Chuck Maack and Murray Corwin. The recipients of the Catalyst Award, given to organizations for their contributions to research, were Medivation and Astellas, Inc.
The 2012 conference was moderated by the University of Michigan’s Dr. Mark Moyad, and featured sessions by world-renowned prostate cancer experts, including Dr. John Mulhall of the Memorial Sloan Kettering Cancer Center, the Mayo Clinic’s Dr. Eugene Kwon, and UCLA’s Dr. Michael Steinberg, among many others.
“I want them [patients] to be empowered,” said Dr. Moyad, when asked what he wanted men to take away from the conference. “This is proof that knowledge is power. So, if they’re attending the sessions, if they pick up the video, if they go to the website, they will be empowered.”
The Prostate Cancer Research Institute is a charitable non-profit organization dedicated to supporting research to improve the quality of men’s lives, and providing information that both educates and empowers patients, families and the medical community. Founded in 1996 by internationally recognized prostate cancer oncologists Mark C. Scholz, MD and Stephen B. Strum, MD, with support from Daniel Freeman Hospital Foundation, PCRI provides programs and services to support their mission and goals. Such programs and resources include a help line, an informative and up-to-date website, newsletters, annual conferences, advocacy, and research.
Visit us at http://www.prostate-cancer.org